| 1 |
34169421 | All-trans Retinoic Acid, Arsenic Trioxide, and Anthracycline-based Chemotherapy Improves Outcome in Newly Diagnosed Acute Promyelocytic Leukemia Regardless of FLT3-ITD Mutation Status. | 2021 Jun |
2 |
| 2 |
32536235 | Arsenic trioxide and all-trans retinoic acid suppress the expression of FLT3-ITD. | 2020 Nov |
6 |
| 3 |
32565734 | Arsenic trioxide potentiates Gilteritinib-induced apoptosis in FLT3-ITD positive leukemic cells via IRE1a-JNK-mediated endoplasmic reticulum stress. | 2020 |
1 |
| 4 |
29959200 | Arsenic Trioxide and Sorafenib Induce Synthetic Lethality of FLT3-ITD Acute Myeloid Leukemia Cells. | 2018 Sep |
4 |
| 5 |
30250637 | Combination of ATO with FLT3 TKIs eliminates FLT3/ITD+ leukemia cells through reduced expression of FLT3. | 2018 Aug 31 |
7 |
| 6 |
28276286 | Arsenic trioxide and all-trans-retinoic acid selectively exert synergistic cytotoxicity against FLT3-ITD AML cells via co-inhibition of FLT3 signaling pathways. | 2017 Oct |
9 |
| 7 |
27133819 | PML-RARĪ± kinetics and impact of FLT3-ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy. | 2016 Oct |
1 |
| 8 |
24160850 | Arsenic trioxide in front-line therapy of acute promyelocytic leukemia (C9710): prognostic significance of FLT3 mutations and complex karyotype. | 2014 Jul |
2 |
| 9 |
22791509 | Molecular markers in acute myeloid leukaemia. | 2012 Aug |
1 |
| 10 |
17336255 | Treatment of relapsed or refractory acute promyelocytic leukemia. | 2007 Mar |
1 |
| 11 |
17050201 | Synergistic effect of arsenic trioxide and flt3 inhibition on cells with flt3 internal tandem duplication. | 2006 Oct |
3 |
| 12 |
17121903 | Arsenic trioxide affects signal transducer and activator of transcription proteins through alteration of protein tyrosine kinase phosphorylation. | 2006 Nov 15 |
1 |